Enhancing Patient Care and Addressing Progression with Immune Checkpoint Inhibitors in Non-Melanoma Skin Cancers
This enduring activity is designed for healthcare professionals involved in the management of patients with non-melanoma skin cancers (NMSCs). This case-based presentation—led by expert faculty and enriched with Patient Spotlight Videos—address complex and evolving NMSC cases to enhance clinical decision-making and patient outcomes. Participants will gain practical insights into modern treatment selection, the expanding role of immune checkpoint inhibitors, and effective multidisciplinary and patient-centered care strategies. Supporting resources, including an engaging Whiteboard Animation, will reinforce key concepts, promoting sustained improvement in care delivery across academic and community dermatology practices nationwide.
RELEASED DATE: January 23, 2026
EXPIRATION DATE: January 23, 2027
Improving Patient Outcomes in Non-Melanoma Skin Cancers: Advances in Checkpoint Inhibition, Risk Stratification, and Patient-Centered Care
This program is designed to address persistent clinical gaps in the management of nonmelanoma skin cancers (NMSCs), particularly in identifying and treating high-risk disease. The program is structured to improve clinicians’ knowledge, competence, and confidence by enabling them to identify key diagnostic and stratification criteria to promptly and accurately recognize high-risk NMSC. Building on this foundation, the education integrates current clinical data for emerging neoadjuvant and adjuvant immunotherapies, supporting clinicians in incorporating these approaches into treatment strategies to optimize surgical outcomes and reduce recurrence risk. Additionally, the program emphasizes the importance of coordinated, patient-centered care by developing strategies for clinicians to work effectively within the multidisciplinary team and engage patients in shared decision-making, ultimately enhancing communication, care alignment, and overall outcomes in high-risk NMSC management.
RELEASED DATE: May 30, 2026
EXPIRATION DATE: May 30, 2027
Improving Patient Outcomes in Non-Melanoma Skin Cancers: Advances in Checkpoint Inhibition, Risk Stratification, and Patient-Centered Care
This program is designed to address persistent clinical gaps in the management of nonmelanoma skin cancers (NMSCs), particularly in identifying and treating high-risk disease. The program is structured to improve clinicians’ knowledge, competence, and confidence by enabling them to identify key diagnostic and stratification criteria to promptly and accurately recognize high-risk NMSC. Building on this foundation, the education integrates current clinical data for emerging neoadjuvant and adjuvant immunotherapies, supporting clinicians in incorporating these approaches into treatment strategies to optimize surgical outcomes and reduce recurrence risk. Additionally, the program emphasizes the importance of coordinated, patient-centered care by developing strategies for clinicians to work effectively within the multidisciplinary team and engage patients in shared decision-making, ultimately enhancing communication, care alignment, and overall outcomes in high-risk NMSC management.
RELEASED DATE: June 05, 2026
EXPIRATION DATE: June 05, 2027
Instructional on Neoadjuvant and Adjuvant ICIs for NMSC in Clinical Practice
This program is designed to address persistent clinical gaps in the management of nonmelanoma skin cancers (NMSCs), particularly in identifying and treating high-risk disease. The program is structured to improve clinicians’ knowledge, competence, and confidence by enabling them to identify key diagnostic and stratification criteria to promptly and accurately recognize high-risk NMSC. Building on this foundation, the education integrates current clinical data for emerging neoadjuvant and adjuvant immunotherapies, supporting clinicians in incorporating these approaches into treatment strategies to optimize surgical outcomes and reduce recurrence risk. Additionally, the program emphasizes the importance of coordinated, patient-centered care by developing strategies for clinicians to work effectively within the multidisciplinary team and engage patients in shared decision-making, ultimately enhancing communication, care alignment, and overall outcomes in high-risk NMSC management.
RELEASED DATE: May 30, 2026
EXPIRATION DATE: May 30, 2027
Next Steps for Immune Checkpoint Inhibitors in Non-Melanoma Skin Cancers: Expert Guidance to Enhance Patient Care
With multiple immunotherapy treatment options and combinations available for the management of melanoma, clinicians require up-to-date guidance on the application of clinical data—including recent findings presented at ASCO—to support shared decision-making and multidisciplinary care. In this concise program, Dr. Emily Ruiz reviews current evidence-based guidelines, presents clinical data informing treatment decisions, and demonstrates best practices for applying this data to patients with melanoma.
RELEASED DATE: July 31, 2025
EXPIRATION DATE: July 31, 2026
Review of the Evolving Treatment Landscape for Patients with Non-Melanoma Skin Cancers
This program will dive into the latest advances in the management of non-melanoma skin cancers (NMSCs), including new data presented at ESMO. Through real-world clinical cases, faculty will guide participants in applying emerging evidence—particularly regarding neoadjuvant and adjuvant immune checkpoint inhibitors—to personalize treatment based on patient- and disease-specific risk factors. The session will also emphasize shared decision-making and multidisciplinary care to support coordinated, patient-centered treatment planning for individuals with advanced NMSCs.
RELEASED DATE: November 21, 2025
EXPIRATION DATE: November 21, 2026
